Onorach Clinical Clinical Trial Support Services
Onorach Clinical is a clinical trial support company specialising in supporting our clients’ set up and delivery of clinical trials covering Phases I to IV. We’re also experienced in clinical trial services for medical devices and cell-based therapeutics.
We’re a young, fast-growing company focused on providing a fresh approach to our industry. Based in the north-east of Scotland, UK, but operating globally, we offer our clients the same high level of service anywhere in the world.
Tailored clinical trial support services
We pride ourselves on our growing reputation for our pro-active, tailored approach in delivering comprehensive and innovative solutions to the challenges faced in clinical trials.
A strong customer focus and detailed knowledge are at the heart of everything we do; that’s why we’re confident that we can help you deliver your clinical trial efficiently, cost-effectively and to the very highest standards.
Clinical trial site selection services
Our Right-Sites service is designed to identify, qualify and select the right sites for your clinical trial. This is a complex issue and involves the assessment of a number of factors including:
- Adequate resources on-site for the study
- Integrity of the research team (ICH-GCP compliant)
- Accuracy in estimates of patient recruitment numbers and focus on early patient recruitment to meet the trial objectives and timelines
- All research staff need to have a positive attitude towards the research study
An evaluation of these and other factors in our Right-Sites service makes for a stronger and more robust project and improves delivery of project time lines within budget.
Principal investigator selection services
Finding the optimal principal investigator (PI) is one of the biggest challenges in clinical trials. Not only must they be expert in the required therapeutic area, and have up-to-date experience in Good Clinical Practice (GCP), but they must also be enthusiastic about your trial and prepared to discuss issues with the CRO / sponsor as they arise to ensure the trial remains on time and on budget.
Even the best and most sought-after PIs only have so many hours in a day so we make sure that our PIs are ready to start the project when you are. Our Optimal» PI service addresses all of these issues to ensure the optimal progress of your clinical trial.
Clinical and medical liaison service
At Onorach we look beyond traditional sponsor / CRO models to provide the solutions that sponsors want for clinical trial challenges.
Onorach’s clinical and medical liaison service (OCMLS) is one such solution and is designed to maintain the balance between clinical objectives and business, with Onorach providing the communication bridge between research consultants, sponsor staff and all members of the research team. This takes the communications burden away from the drug development company and ensures that timely communications on-site will prevent minor issues escalating into larger problems which will affect a sponsor and study time-lines.
At a time when the industry is undergoing dynamic changes OCMLS is one of the most effective means of shortening the time to peak study optimisation.
CRO services for drug development
All of the above services can be taken separately or in combination, and we also provide a full range of traditional CRO services such as monitoring and project management.
Our aim is to partner with sponsors in the drug development process, helping our clients address any issue related to the clinical trial process. For a relationship so close, it is important to choose the right partner. Our CRO-sponsorship relationship is one of a shared vision, complementary expertise and trust.
ICH-GCP compliant clinical trial support personnel
We firmly believe our people are our product; that’s why we invest in equipping our team with the most comprehensive training and skill sets available. Every member of our team is ICH-GCP compliant and works to the highest ethical and professional standards, and our team have experience in a wide range of therapeutic areas.
Call or email us now to find out how we can help you.
Products and Services
Fujifilm Corporation and Merck, known as MSD outside the US and Canada, have announced that they have entered into a definitive agreement by which Fujifilm will acquire the Merck BioManufacturing Network, a leading provider of contract manufacturing and development services for the biopharmaceutRead more
ACE Pharmaceuticals today announced that the first patient has entered the Phase III trial also known as the Levamisole trial. This trial was accepted by the EMEA by November 2006. The goal of this trial, which was accepted by the EMEA in November 2006, is to assess the efficacy and saRead more
PROTEO Biotech AG and ARTES Biotechnology GmbH: Strategic Alliance for Marketing of Elafin in Asia, Africa and South America
Kiel - Erkrath, June 19, 2006. PROTEO Biotech AG, a wholly owned subsidiary of PROTEO Inc., USA, has signed a cooperation agreement with ARTES Biotechnology GmbH. The aim of the agreement is the marketing of Elafin, the lead product of PROTEO Biotech AG / PROTEO Inc., in India, Egypt and ArgentinRead more